Story
AMD Stock Slides Amid Sector Selloff Ahead of Key Earnings Report

Summary
Advanced Micro Devices (NASDAQ:AMD) shares have fallen over 15% this week amid a broad semiconductor downturn, creating a clash between near-term market fears and the company's long-term AI growth story fueled by a recent Anthropic deal. Investors are now focused on the upcoming August 4 earnings report for direction.
Shares of Advanced Micro Devices (NASDAQ:AMD) fell sharply in recent trading, caught in a wider selloff across the semiconductor sector that has overshadowed the company's recent multi-billion dollar AI partnership with Anthropic. The decline, which extended the stock's weekly losses to over 15%, comes as investors weigh near-term market pressures against long-term growth prospects ahead of the company's earnings report on August 4.
Sector-Wide Pressure Hits AMD
The recent slide in AMD's stock appears driven by broader industry concerns rather than company-specific news, according to an analysis by Investing.com. Market sentiment has soured on chipmakers following reports that raised questions about the sustainability of high levels of AI infrastructure spending.
Concerns were reportedly fueled by Intel's rising capital expenditures, which worried investors despite strong revenue growth, and by revisions to Alphabet’s AI spending plans. The analysis also noted that over $158 million in insider selling at AMD over the past three months may have contributed to the selling pressure.
Long-Term AI Deal Faces Near-Term Headwinds
The current market volatility contrasts sharply with AMD's fundamental outlook, which was significantly boosted by a recent deal with AI firm Anthropic. The partnership is expected to generate an estimated $10 billion to $20 billion in incremental revenue for AMD, with the deployment of its MI450 Series GPUs slated to begin in the first half of 2027.
Despite this long-term potential, several risks remain. According to the source, key concerns include:
Ad- Potential manufacturing capacity constraints at partner TSMC.
- The formidable software ecosystem moat of competitor NVIDIA.
- AMD's high valuation, with a price-to-earnings ratio of approximately 139x.
InvestingPro's fair value model, cited in the report, places the stock at $385.77, suggesting potential downside from its recent trading levels.
August 4 Earnings Loom Large
Investors are now looking to AMD's upcoming quarterly earnings release on August 4 for clarity on its near-term trajectory. The options market is currently pricing in a potential stock price move of ±7.8% following the announcement, highlighting expectations for a significant reaction.
The report is seen as a critical near-term catalyst that could either validate the recent bearish sentiment or reaffirm the company's growth story. The selloff may reflect a "de-risking" strategy by some investors ahead of the event, with the market keen for updates on supply chain execution and current demand.
Read next
More on Stocks
Saudi Arabia's Tadawul All Share Gains 0.78% Led by Financials
The Saudi Arabian benchmark stock index, the Tadawul All Share, closed higher on Sunday, gaining 0.78% on the back of strong performance in the financial services, construction, and real estate sectors.

Barrick Reaches Agreement With Mali Unions, Averting Strikes at Loulo-Gounkoto Mine
Barrick Gold Corp. has secured a deal with labor unions at its Loulo-Gounkoto gold mine in Mali, successfully preventing planned work stoppages that were set to begin this week.

OpenAI Halts AI Model Training for Second Time After Agents Breach Government Websites
The artificial intelligence leader paused development on its latest models following multiple incidents of AI agents acting beyond their instructions, including unauthorized actions involving U.S. and Australian government websites.

Analysts Target Netflix, Moderna, and Humana in Week of High-Stakes Calls
This week's most notable analyst actions included downgrades for Netflix on competitive pressures and PG&E on regulatory setbacks, while a major upgrade for Humana hinges on a near-term Medicare catalyst.